Literature DB >> 22032431

Chronic obstructive pulmonary disease: a concise review.

Ron Balkissoon1, Steve Lommatzsch, Brendan Carolan, Barry Make.   

Abstract

Globally, chronic obstructive pulmonary disease (COPD) is a major cause of significant morbidity and mortality, and is now the third leading cause of death in the United States. Over the past 15 years there has been a surge of bench and translational research regarding the genetics and pathogenesis of COPD, and several large-scale clinical trials have introduced new treatment paradigms for COPD. Current research also demonstrates that COPD is not just a lung disease and that there are several potential extrapulmonary manifestations and comorbidities that should be evaluated and treated when one identifies an individual as having COPD.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22032431     DOI: 10.1016/j.mcna.2011.08.009

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  20 in total

1.  Role of CXCL5 in leukocyte recruitment to the lungs during secondhand smoke exposure.

Authors:  Gayathriy Balamayooran; Sanjay Batra; Shanshan Cai; Junjie Mei; G Scott Worthen; Arthur L Penn; Samithamby Jeyaseelan
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02-23       Impact factor: 6.914

Review 2.  Adult stem cells underlying lung regeneration.

Authors:  Wa Xian; Frank McKeon
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

3.  N-acetylcysteine protects murine alveolar type II cells from cigarette smoke injury in a nuclear erythroid 2-related factor-2-independent manner.

Authors:  Elise M Messier; Brian J Day; Karim Bahmed; Steven R Kleeberger; Rubin M Tuder; Russell P Bowler; Hong Wei Chu; Robert J Mason; Beata Kosmider
Journal:  Am J Respir Cell Mol Biol       Date:  2013-05       Impact factor: 6.914

4.  Temporal and Spatial Expression of Transforming Growth Factor-β after Airway Remodeling to Tobacco Smoke in Rats.

Authors:  Laura L Hoang; Yen P Nguyen; Rayza Aspeé; Sarah J Bolton; Yi-Hsin Shen; Lei Wang; Nicholas J Kenyon; Suzette Smiley-Jewell; Kent E Pinkerton
Journal:  Am J Respir Cell Mol Biol       Date:  2016-06       Impact factor: 6.914

5.  Bioactive lipid profiling reveals drug target engagement of a soluble epoxide hydrolase inhibitor in a murine model of tobacco smoke exposure.

Authors:  Malin L Nording; Jun Yang; Laura Hoang; Vanessa Zamora; Dale Uyeminami; Imelda Espiritu; Kent E Pinkerton; Bruce D Hammock; Ayala Luria
Journal:  J Metabolomics       Date:  2015-04-04

6.  Increased serum levels of lipocalin-1 and -2 in patients with stable chronic obstructive pulmonary disease.

Authors:  Xiao-ru Wang; Yong-pu Li; Shui Gao; Wei Xia; Kun Gao; Qing-hua Kong; Hui Qi; Ling Wu; Jing Zhang; Jie-ming Qu; Chun-xue Bai
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-05-27

7.  Interim Report from Burden of Obstructive Lung Disease (BOLD Study) in Tehran: Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease.

Authors:  Hooman Sharifi; Mohammad Reza Masjedi; Habib Emami; Mostafa Ghanei; Alireza Eslaminejad; Golnar Radmand; A Sonia Buist
Journal:  Tanaffos       Date:  2014

8.  Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.

Authors:  Jing Zhang; Xin-feng Lin; Chun-xue Bai
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-01-08

9.  Burden of obstructive lung disease study in Tehran: Prevalence and risk factors of chronic obstructive pulmonary disease.

Authors:  Hooman Sharifi; Mohammad Reza Masjedi; Habib Emami; Mostafa Ghanei; Alireza Eslaminejad; Golnar Radmand; Sonia Buist
Journal:  Lung India       Date:  2015 Nov-Dec

10.  A machine learning approach to triaging patients with chronic obstructive pulmonary disease.

Authors:  Sumanth Swaminathan; Klajdi Qirko; Ted Smith; Ethan Corcoran; Nicholas G Wysham; Gaurav Bazaz; George Kappel; Anthony N Gerber
Journal:  PLoS One       Date:  2017-11-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.